Key facts
- This page summarizes Cano Health, Inc.'s Form 4 filing for MSP Recovery, Inc. (MSPR).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Apr 2024, 16:34.
Cano Health, Inc. - 01 Apr 2024 Form 4 Insider Report for MSP Recovery, Inc. (MSPR)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- MSPR
- Reported as of
- 01 Apr 2024
- Net transaction value
- -$996,712
- SEC form
- 4
- Accepted by SEC
- 03 Apr 2024, 16:34:33 UTC
- Prior SEC filing
- 29 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- Cano Health, Inc., By: /s/ David J. Armstrong, Name: David J. Armstrong, Title: General Counsel
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Cano Health, Inc. filed Form 4 for MSP Recovery, Inc. (MSPR) on 03 Apr 2024.
Change
- Previous filing in this sequence was filed on 29 Mar 2024.
- Current net transaction value: -$996,712.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LIFW
transaction
Class A Common Stock
Sale
- Transaction value
- $20,352
- Shares
- -30,376
- Change %
- -1.5%
- Price
- $0.6700
- Shares after
- 2,013,155
- Date
- 01 Apr 2024
- Ownership
- See Footnote
- Footnotes
- F1, F2
LIFW
transaction
Class A Common Stock
Sale
- Transaction value
- $976,360
- Shares
- -1,109,500
- Change %
- -55%
- Price
- $0.8800
- Shares after
- 903,655
- Date
- 02 Apr 2024
- Ownership
- See Footnote
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Cano Health, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6642 to $0.6789. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F2
Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.
Footnote F3
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.72 to $1.035. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.